Sunday, September 12, 2010

Roche Suspends Diabetes Drug Trial - WSJ.com

ZURICH—Roche Holding AG has suspended late-stage trials of experimental diabetes drug taspoglutide due to side effects in another heavy blow to its medical pipeline, which is scheduled to be revamped after a series of development failures.

Posted via email from Jack's posterous

No comments: